| Immune landscape of viral-and carcinogen-driven head and neck cancer AR Cillo, CHL Kürten, T Tabib, Z Qi, S Onkar, T Wang, A Liu, U Duvvuri, ... Immunity 52 (1), 183-199. e9, 2020 | 459 | 2020 |
| B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma AT Ruffin, AR Cillo, T Tabib, A Liu, S Onkar, SR Kunning, C Lampenfeld, ... Nature communications 12 (1), 3349, 2021 | 181 | 2021 |
| Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing CHL Kürten, A Kulkarni, AR Cillo, PM Santos, AK Roble, S Onkar, ... Nature communications 12 (1), 7338, 2021 | 129 | 2021 |
| Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors L Zhu, JL Narloch, S Onkar, M Joy, G Broadwater, C Luedke, A Hall, ... Journal for immunotherapy of cancer 7, 1-10, 2019 | 93 | 2019 |
| The great immune escape: understanding the divergent immune response in breast cancer subtypes SS Onkar, NM Carleton, PC Lucas, TC Bruno, AV Lee, DAA Vignali, ... Cancer discovery 13 (1), 23-40, 2023 | 64 | 2023 |
| Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition S Cascio, C Chandler, L Zhang, S Sinno, B Gao, S Onkar, TC Bruno, ... Science advances 7 (46), eabi5790, 2021 | 46 | 2021 |
| ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation Z Li, O McGinn, Y Wu, A Bahreini, NM Priedigkeit, K Ding, S Onkar, ... Nature Communications 13 (1), 2011, 2022 | 41 | 2022 |
| Ewing sarcoma and osteosarcoma have distinct immune signatures and intercellular communication networks AR Cillo, E Mukherjee, NG Bailey, S Onkar, J Daley, C Salgado, X Li, ... Clinical Cancer Research 28 (22), 4968-4982, 2022 | 25 | 2022 |
| Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironment S Onkar, J Cui, J Zou, C Cardello, AR Cillo, MR Uddin, A Sagan, M Joy, ... Nature Cancer 4 (4), 516-534, 2023 | 22 | 2023 |
| Liposome-encapsulated human immunodeficiency virus-1 gp120 induces potent V1V2-specific antibodies in humans M Rao, S Onkar, KK Peachman, Y White, HV Trinh, O Jobe, Y Zhou, ... The Journal of infectious diseases 218 (10), 1541-1550, 2018 | 22 | 2018 |
| People critically ill with COVID-19 exhibit peripheral immune profiles predictive of mortality and reflective of SARS-CoV-2 lung viral burden AR Cillo, A Somasundaram, F Shan, C Cardello, CJ Workman, GD Kitsios, ... Cell Reports Medicine 2 (12), 2021 | 15 | 2021 |
| Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant Y Wen, HV Trinh, CE Linton, C Tani, N Norais, DA Martinez-Guzman, ... PLoS One 13 (4), e0194266, 2018 | 15 | 2018 |
| Human Primary Macrophages Derived In Vitro from Circulating Monocytes Comprise Adherent and Non-Adherent Subsets with Differential Expression of Siglec-1 … O Jobe, J Kim, E Tycksen, S Onkar, NL Michael, CR Alving, M Rao Frontiers in immunology 8, 1352, 2017 | 15 | 2017 |
| Bifurcated monocyte states are predictive of mortality in severe COVID-19 AR Cillo, A Somasundaram, F Shan, C Cardello, CJ Workman, GD Kitsios, ... bioRxiv, 2021 | 6 | 2021 |
| Divergent cancer etiologies drive distinct B cell signatures and tertiary lymphoid structures AT Ruffin, AR Cillo, T Tabib, A Liu, S Onkar, S Kunning, C Lampenfeld, ... BioRxiv, 2020.05. 29.123265, 2020 | 6 | 2020 |
| Frequent and durable anti-hiv envelope viv2 igg responses induced by hiv-1 dna priming and hiv-mva boosting in healthy tanzanian volunteers A Joachim, F Msafiri, S Onkar, P Munseri, S Aboud, EF Lyamuya, ... Vaccines 8 (4), 681, 2020 | 5 | 2020 |
| Standardization of a cytometric p24-capture bead-assay for the detection of main HIV-1 subtypes. M Merbah, S Onkar, JC Grivel, C Vanpouille, A Biancotto, L Bonar, ... Journal of virological methods 230, 45-52, 2016 | 5 | 2016 |
| Army Liposome Formulation Augments the Immunogenicity of HIV-1 AIDSVAX® B/E Protein J Kim, A Allam, KK Peachman, S Onkar, GR Matyas, F Sinangil, CR Alving, ... The Journal of Immunology 210 (1_Supplement), 223.16-223.16, 2023 | | 2023 |
| Research briefing S Onkar, S Oesterreich, DAA Vignali Nature 4, 450-451, 2023 | | 2023 |
| Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironment (Mar, 10.1038/s43018-023-00527-w, 2023) S Onkar, J Cui, J Zou, C Cardello, AR Cillo, MR Uddin, A Sagan, M Joy, ... NATURE CANCER 4 (4), 582-582, 2023 | | 2023 |
